Aurora leading sector consolidationI invested in Aurora because it's hard to ignore the sector today and they seem to me to have a solid management team with an impressive strategy and recent acquisitions seem to have been well considered. Medleaf offers a solid product slate, r&d depth and more market reach....so IMHO a very attractive value play IMHO. But geesh...they really paid up for it...arguably too much on current metrics. Growth pressures will be enormous for the foreseeable future. But I have no real confidence about how to predict growth in this sector...I want to believe that the demand is immense both recreationally and that medicinal/clinical applications will ultimately have a profound impact on future health care sectors. Suspect we might see some nice bumps along the way but I guess it will take time for rewards to flow through decisively for shareholders?. This article is interesting:
https://www.forbes.com/sites/greatspeculations/2018/06/04/why-did-aurora-cannabis-pay-such-a-high-price-for-medreleaf-corp/2/ Cheers, GE